United Capital Financial Advisers LLC grew its position in Centene Co. (NYSE:CNC – Get Rating) by 7.2% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 103,775 shares of the company’s stock after purchasing an additional 6,929 shares during the period. United Capital Financial Advisers LLC’s holdings in Centene were worth $8,780,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. Fieldpoint Private Securities LLC raised its holdings in Centene by 112.0% in the second quarter. Fieldpoint Private Securities LLC now owns 335 shares of the company’s stock worth $28,000 after purchasing an additional 177 shares during the period. Massmutual Trust Co. FSB ADV raised its holdings in shares of Centene by 145.5% during the second quarter. Massmutual Trust Co. FSB ADV now owns 356 shares of the company’s stock worth $30,000 after acquiring an additional 211 shares during the period. Crewe Advisors LLC acquired a new stake in shares of Centene during the second quarter worth $31,000. Larson Financial Group LLC raised its holdings in shares of Centene by 30.1% during the second quarter. Larson Financial Group LLC now owns 592 shares of the company’s stock worth $50,000 after acquiring an additional 137 shares during the period. Finally, CoreCap Advisors LLC acquired a new stake in shares of Centene during the second quarter worth $51,000. 94.74% of the stock is currently owned by institutional investors and hedge funds.
Centene Stock Performance
Shares of CNC stock opened at $83.63 on Thursday. Centene Co. has a 52 week low of $69.51 and a 52 week high of $98.53. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.06 and a current ratio of 1.06. The company has a 50-day simple moving average of $80.36 and a 200 day simple moving average of $84.91. The company has a market capitalization of $47.36 billion, a price-to-earnings ratio of 24.38, a PEG ratio of 1.08 and a beta of 0.60.
Wall Street Analysts Forecast Growth
CNC has been the subject of a number of analyst reports. Wells Fargo & Company downgraded shares of Centene from an “overweight” rating to an “equal weight” rating and decreased their target price for the company from $103.00 to $99.00 in a research report on Friday, August 26th. Truist Financial raised their target price on shares of Centene from $102.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, July 27th. StockNews.com initiated coverage on shares of Centene in a research report on Wednesday, October 12th. They issued a “strong-buy” rating for the company. Stephens raised their target price on shares of Centene to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, July 27th. Finally, Argus initiated coverage on shares of Centene in a research report on Friday, September 30th. They issued a “buy” rating and a $90.00 price objective for the company. Four analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $98.68.
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs.
- Get a free copy of the StockNews.com research report on Centene (CNC)
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Microsoft Shares: Is it Time to Back Up the Truck?
- Institutional Support for Analog Devices Remains High
- Is the 60/40 Portfolio Mix Still in Vogue?
- Three CBD Stocks to Dominate a Budding Industry
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.